Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Royalty Pharma plc

NASDAQ: RPRX · Life Sciences · 6 alerts · CIK 1802768

Share price
$68.53Close, Nov 16
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Royalty Pharma plc filings on SEC EDGAR ↗

5:13 PM ET Form 4
Insider Selling

Royalty Pharma EVP, Research & Investments Marshall Urist Sells $236K of Stock

Marshall Urist, EVP, Research & Investments, sold 4,126 shares of Royalty Pharma plc at $57.10 a share, worth $236K in total on Oct 5, 2026. Shares held after the trade: 0 (-100.0%).

Value
$236K
Shares
4,126
Price
$57.10
Role
EVP, Research & Investments
Holding change
-100.0%
Trade date
Oct 5, 2026
4:32 PM ET Form 4
Insider Selling

Royalty Pharma EVP, Research & Investments Marshall Urist Sells $239K of Stock

Marshall Urist, EVP, Research & Investments, sold 4,126 shares of Royalty Pharma plc at $57.88 a share, worth $239K in total on Sep 28, 2026. Shares held after the trade: 4,126 (-50.0%).

Value
$239K
Shares
4,126
Price
$57.88
Role
EVP, Research & Investments
Holding change
-50.0%
Trade date
Sep 28, 2026
4:12 PM ET Form 4
Insider Selling

Royalty Pharma EVP & Chairman, Partnering Christopher Hite Sells $5.85M of Stock

Christopher Hite, EVP & Chairman, Partnering, sold 100,000 shares of Royalty Pharma plc at $58.51 to $58.93 a share (average $58.53) in 2 transactions, worth $5.85M in total on Sep 22, 2026. Shares held after the trade: 270,401 (-1.4%).

Value
$5.85M
Shares
100,000
Average price
$58.53
Role
EVP & Chairman, Partnering
Holding change
-1.4%
Trade date
Sep 22, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.